Controlled trial of hypnotherapy in the treatment of severe refractory irritable-bowel syndrome - PubMed (original) (raw)

Clinical Trial

Controlled trial of hypnotherapy in the treatment of severe refractory irritable-bowel syndrome

P J Whorwell et al. Lancet. 1984.

Abstract

30 patients with severe refractory irritable-bowel syndrome were randomly allocated to treatment with either hypnotherapy or psychotherapy and placebo. The psychotherapy patients showed a small but significant improvement in abdominal pain, abdominal distension, and general well-being but not in bowel habit. The hypnotherapy patients showed a dramatic improvement in all features, the difference between the two groups being highly significant. In the hypnotherapy group no relapses were recorded during the 3-month follow-up period, and no substitution symptoms were observed.

PubMed Disclaimer

Similar articles

• Individual and group hypnotherapy in treatment of refractory irritable bowel syndrome.
  Harvey RF, Hinton RA, Gunary RM, Barry RE. Harvey RF, et al. Lancet. 1989 Feb 25;1(8635):424-5. doi: 10.1016/s0140-6736(89)90013-5. Lancet. 1989. PMID: 2563797 Clinical Trial.
• Changes in rectal sensitivity after hypnotherapy in patients with irritable bowel syndrome.
  Prior A, Colgan SM, Whorwell PJ. Prior A, et al. Gut. 1990 Aug;31(8):896-8. doi: 10.1136/gut.31.8.896. Gut. 1990. PMID: 2387513 Free PMC article.
• Psychological treatments for irritable bowel syndrome: a critique of controlled treatment trials.
  Talley NJ, Owen BK, Boyce P, Paterson K. Talley NJ, et al. Am J Gastroenterol. 1996 Feb;91(2):277-83. Am J Gastroenterol. 1996. PMID: 8607493 Review.
• Hypnotherapy and refractory irritable bowel syndrome: a single case study.
  Galovski TE, Blanchard EB. Galovski TE, et al. Am J Clin Hypn. 2002 Jul;45(1):31-7. doi: 10.1080/00029157.2002.10403495. Am J Clin Hypn. 2002. PMID: 12116613
• Use of hypnotherapy in gastrointestinal disorders.
  Francis CY, Houghton LA. Francis CY, et al. Eur J Gastroenterol Hepatol. 1996 Jun;8(6):525-9. doi: 10.1097/00042737-199606000-00004. Eur J Gastroenterol Hepatol. 1996. PMID: 8823562 Review.

Cited by

• Gut-directed hypnosis and hypnotherapy for irritable bowel syndrome: a mini-review.
  Häuser W. Häuser W. Front Psychol. 2024 Jun 3;15:1389911. doi: 10.3389/fpsyg.2024.1389911. eCollection 2024. Front Psychol. 2024. PMID: 38887623 Free PMC article. Review.
• Nerva, a mobile application of gut-directed hypnotherapy for irritable bowel syndrome: User characteristics, patterns of use, and predictors of persistence.
  Simicich L, Muniz V, Scheffrahn K, Elkins G. Simicich L, et al. Digit Health. 2024 Jun 14;10:20552076241263257. doi: 10.1177/20552076241263257. eCollection 2024 Jan-Dec. Digit Health. 2024. PMID: 38882251 Free PMC article.
• Acute and Long-Term Effects of App-Delivered Heartfulness Meditation on Psychological Outcomes and the Endocannabinoid Signaling System in Cyclic Vomiting Syndrome.
  Venkatesan T, Hillard CJ, Ayer L, Arumugam S, Culp S, Vyas M, Gofar K, Petrova A, Palsson OS. Venkatesan T, et al. Clin Transl Gastroenterol. 2024 Jul 1;15(7):e00711. doi: 10.14309/ctg.0000000000000711. Clin Transl Gastroenterol. 2024. PMID: 38713142 Free PMC article.
• Unmet needs of drugs for irritable bowel syndrome and inflammatory bowel diseases: interest of vagus nerve stimulation and hypnosis.
  Bonaz B. Bonaz B. Inflammopharmacology. 2024 Apr;32(2):1005-1015. doi: 10.1007/s10787-024-01446-7. Epub 2024 Mar 21. Inflammopharmacology. 2024. PMID: 38512653 Review.
• Hypnotherapy and IBS: Implicit, long-term stress memory in the ENS?
  Császár-Nagy N, Bókkon I. Császár-Nagy N, et al. Heliyon. 2022 Dec 30;9(1):e12751. doi: 10.1016/j.heliyon.2022.e12751. eCollection 2023 Jan. Heliyon. 2022. PMID: 36685398 Free PMC article. Review.

Publication types

MeSH terms

LinkOut - more resources

• Full Text Sources

  • Elsevier Science

• Medical

  • MedlinePlus Health Information